Core Laboratories (NYSE:CLB) Price Target Raised to $18.00 at Stifel Nicolaus

Core Laboratories (NYSE:CLBFree Report) had its price target raised by Stifel Nicolaus from $17.00 to $18.00 in a research note published on Friday, Benzinga reports. Stifel Nicolaus currently has a hold rating on the oil and gas company’s stock.

A number of other research analysts have also weighed in on CLB. Bank of America reduced their target price on Core Laboratories from $17.00 to $16.00 and set an underperform rating for the company in a report on Monday, April 15th. StockNews.com raised Core Laboratories from a sell rating to a hold rating in a report on Saturday, January 20th. Two investment analysts have rated the stock with a sell rating and three have issued a hold rating to the company. Based on data from MarketBeat, Core Laboratories currently has a consensus rating of Hold and a consensus price target of $18.75.

Read Our Latest Analysis on CLB

Core Laboratories Trading Down 0.8 %

Shares of CLB opened at $16.94 on Friday. The business has a 50-day moving average of $16.34 and a 200 day moving average of $17.62. Core Laboratories has a fifty-two week low of $13.82 and a fifty-two week high of $27.94. The firm has a market cap of $793.81 million, a P/E ratio of 19.25, a price-to-earnings-growth ratio of 0.97 and a beta of 2.40. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.72 and a current ratio of 2.68.

Core Laboratories (NYSE:CLBGet Free Report) last announced its quarterly earnings data on Wednesday, April 24th. The oil and gas company reported $0.13 earnings per share for the quarter, topping the consensus estimate of $0.11 by $0.02. Core Laboratories had a return on equity of 15.71% and a net margin of 8.18%. The company had revenue of $129.64 million during the quarter, compared to analyst estimates of $124.47 million. As a group, research analysts forecast that Core Laboratories will post 0.8 EPS for the current year.

Core Laboratories Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, May 28th. Stockholders of record on Monday, May 6th will be given a dividend of $0.01 per share. The ex-dividend date of this dividend is Friday, May 3rd. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.24%. Core Laboratories’s dividend payout ratio (DPR) is presently 4.55%.

Institutional Trading of Core Laboratories

Large investors have recently modified their holdings of the business. Congress Asset Management Co. MA lifted its position in Core Laboratories by 17.6% in the 1st quarter. Congress Asset Management Co. MA now owns 1,606,745 shares of the oil and gas company’s stock worth $27,443,000 after buying an additional 240,989 shares during the last quarter. Fisher Asset Management LLC lifted its position in Core Laboratories by 21.6% in the 4th quarter. Fisher Asset Management LLC now owns 754,407 shares of the oil and gas company’s stock worth $13,323,000 after buying an additional 134,227 shares during the last quarter. Van ECK Associates Corp lifted its position in Core Laboratories by 1.0% in the 3rd quarter. Van ECK Associates Corp now owns 707,868 shares of the oil and gas company’s stock worth $16,996,000 after buying an additional 6,703 shares during the last quarter. Invesco Ltd. lifted its position in Core Laboratories by 25.3% in the 3rd quarter. Invesco Ltd. now owns 436,459 shares of the oil and gas company’s stock worth $10,479,000 after buying an additional 88,013 shares during the last quarter. Finally, Envestnet Asset Management Inc. lifted its position in Core Laboratories by 39.7% in the 3rd quarter. Envestnet Asset Management Inc. now owns 328,435 shares of the oil and gas company’s stock worth $7,886,000 after buying an additional 93,354 shares during the last quarter. Institutional investors own 97.81% of the company’s stock.

Core Laboratories Company Profile

(Get Free Report)

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.

Featured Articles

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.